<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1561-3194</journal-id>
<journal-title><![CDATA[Revista de Ciencias Médicas de Pinar del Río]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Ciencias Médicas]]></abbrev-journal-title>
<issn>1561-3194</issn>
<publisher>
<publisher-name><![CDATA[Editorial Ciencias Médicas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1561-31942022000600005</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Caracterización de pacientes con tumores hipofisarios atendidos en el Hospital &#8220;Hermanos Ameijeiras&#8221; entre 2017 y 2019]]></article-title>
<article-title xml:lang="en"><![CDATA[Characterization of patients with pituitary tumors attended at the "Hermanos Ameijeiras" Hospital between 2017 and 2019]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Boffill Carbó]]></surname>
<given-names><![CDATA[Suselys]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Valdés Lorenzo]]></surname>
<given-names><![CDATA[Nedel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Andino-Ruisbal]]></surname>
<given-names><![CDATA[Ernesto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Ciencias Médicas de Pinar del Río Hospital General Docente &#8220;Abel Santamaría Cuadrado&#8221; ]]></institution>
<addr-line><![CDATA[Pinar del Río ]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad de Ciencias Médicas de La Habana Hospital &#8220;Hermanos Ameijeiras&#8221; ]]></institution>
<addr-line><![CDATA[La Habana ]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2022</year>
</pub-date>
<volume>26</volume>
<numero>6</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1561-31942022000600005&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S1561-31942022000600005&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S1561-31942022000600005&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción: el término tumor hipofisario agrupa a una serie de enfermedades misceláneas y se corresponde con lesiones tumorales primarias del parénquima hipofisario.  Objetivo: caracterizar a los pacientes con tumores de hipófisis atendidos en el Hospital Clínico Quirúrgico &#8220;Hermanos Ameijeiras&#8221; entre 2017 y 2019.  Métodos: estudio observacional, descriptivo, longitudinal y prospectivo de los pacientes con diagnóstico de tumores hipofisarios atendidos en la consulta externa de Enfermedades Hipofisarias y el Servicio de Endocrinología del Hospital Clínico Quirúrgico &#8220;Hermanos Ameijeiras&#8221; entre 2017 y 2019. La muestra estuvo conformada por 267. Para la recolección de los datos se emplearon las historias clínicas individuales de los pacientes. Se empleó estadística descriptiva.  Resultados:  predominó el sexo femenino (79,03 %) y los pacientes tumor de hipófisis no funcionante (59,93 %), seguido de aquellos con tumores secretores de prolactina (31,46 %). Solo en un paciente con tumor hipofisario no funcionante el hallazgo fue incidental. El síntoma más común expresado por los pacientes fue la cefalea (85,77 %). En cada tumor funcionante se determinó un exceso de producción de la hormona específica. Se encontró predominio de pacientes con microadenomas (70,79 %).  Conclusiones:  los tumores hipofisiarios fueron comunes en pacientes del sexo femenino, con predominio del tipo no funcionante y microadenomas. Aunque el diagnóstico puede ser incidental, muchos pacientes acuden a consulta con síntomas por efecto de masa como la cefalea. Los pacientes presentan aumento de variables hormonales tumor específicas.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction:  the term pituitary tumor groups a series of miscellaneous diseases and corresponds to primary tumor lesions of the pituitary parenchyma.  Objective:  to characterize patients with pituitary tumors seen at the "Hermanos Ameijeiras" Clinical Surgical Hospital between 2017 and 2019.  Methods:  observational, descriptive, longitudinal and prospective study of patients with a diagnosis of pituitary tumors seen in the outpatient clinic of Pituitary Diseases and the Endocrinology Service of the Clinical Surgical Hospital "Hermanos Ameijeiras" between 2017 and 2019. The sample consisted of 267 patients. The individual medical records of the patients were used for data collection. Descriptive statistics were used.  Results:  female sex predominated (79,03 %) and patients with non-functioning pituitary tumor (59,93 %), followed by those with prolactin-secreting tumors (31,46 %). Only in one patient with non-functioning pituitary tumor the finding was incidental. The most common symptom expressed by the patients was headache (85,77 %). In each functioning tumor an excess production of the specific hormone was determined. A predominance of patients with microadenomas was found (70,79 %).  Conclusions:  Pituitary tumors were common in female patients, with predominance of the non-functioning type and microadenomas. Although the diagnosis may be incidental, many patients present with mass effect symptoms such as headache. Patients present with increased tumor-specific hormones.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[NEOPLASIAS HIPOFISARIAS]]></kwd>
<kwd lng="es"><![CDATA[NEOPLASIAS DEL SISTEMA NERVIOSO]]></kwd>
<kwd lng="es"><![CDATA[ADENOMA HIPOFISARIO SECRETOR DE ACTH]]></kwd>
<kwd lng="es"><![CDATA[ADENOMA HIPOFISARIO SECRETOR DE HORMONA DEL CRECIMIENTO]]></kwd>
<kwd lng="es"><![CDATA[PROLACTINOMA]]></kwd>
<kwd lng="en"><![CDATA[PITUITARY NEOPLASMS]]></kwd>
<kwd lng="en"><![CDATA[NERVOUS SYSTEM NEOPLASMS]]></kwd>
<kwd lng="en"><![CDATA[ACTH-SECRETING PITUITARY ADENOMA]]></kwd>
<kwd lng="en"><![CDATA[ROWTH HORMONE-SECRETING PITUITARY ADENOMA]]></kwd>
<kwd lng="en"><![CDATA[PROLACTINOMA]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Würth]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Thellung]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Corsaro]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Barbieri]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Florio]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Experimental Evidence and Clinical Implications of Pituitary Adenoma Stem Cells.]]></article-title>
<source><![CDATA[Front Endocrinol (Lausanne)]]></source>
<year>2020</year>
<volume>20</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>54</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Anahi Cecenarro]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Moyano Crespo]]></surname>
<given-names><![CDATA[GD]]></given-names>
</name>
<name>
<surname><![CDATA[Mukdsi]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Actualización sobre mecanismos de tumorogénesis hipofisiaria]]></article-title>
<source><![CDATA[Revista de la Facultad de Ciencias Médicas de Córdoba]]></source>
<year>2021</year>
<volume>78</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zatelli]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pathogenesis of non-functioning pituitary adenomas]]></article-title>
<source><![CDATA[Pituitary]]></source>
<year>2018</year>
<volume>2</volume>
<numero>(</numero>
<issue>(</issue>
<page-range>):130-7</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="">
<source><![CDATA[International Agency for Research on Cancer. WHO. Classification of Tumours of Endocrine Organs]]></source>
<year>2017</year>
<edition>4</edition>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Drummond]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Roncaroli]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Grossman]]></surname>
<given-names><![CDATA[AB]]></given-names>
</name>
<name>
<surname><![CDATA[Korbonits]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical and pathological aspects of silent pituitary adenomas]]></article-title>
<source><![CDATA[J Clin Endocrinol Metab]]></source>
<year>2019</year>
<volume>104</volume>
<page-range>2473-89.</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Almeida]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
<name>
<surname><![CDATA[Stephens]]></surname>
<given-names><![CDATA[CC]]></given-names>
</name>
<name>
<surname><![CDATA[Eschbacher]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Felicella]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Yuen]]></surname>
<given-names><![CDATA[KCJ]]></given-names>
</name>
<name>
<surname><![CDATA[White]]></surname>
<given-names><![CDATA[WL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical, pathologic, and imaging characteristics of pituitary null cell adenomas as defined according to the 2017 World Health Organization criteria: A case series from two pituitary centers.]]></article-title>
<source><![CDATA[Pituitary]]></source>
<year>2019</year>
<volume>22</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>514-9</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[López Ruíz]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Dayoub Mejías]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Troncone]]></surname>
<given-names><![CDATA[MG.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Caracterización de pacientes con tumores hipofisarios en la consulta del servicio de endocrinología del Hospital Vargas de Caracas, Venezuela.]]></article-title>
<source><![CDATA[Revista Venezolana de Endocrinología y Metabolismo]]></source>
<year>2021</year>
<volume>19</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>138-48</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Picó]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Aranda-López]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Sesmilo]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Toldos-González]]></surname>
<given-names><![CDATA[Ó]]></given-names>
</name>
<name>
<surname><![CDATA[Japón]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Luque]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Recommendations on the pathological report of pituitary tumors. A consensus of experts of the Spanish Society of Endocrinology and Nutrition and the Spanish Society of Pathology.]]></article-title>
<source><![CDATA[Endocrinol Diabetes Nutr]]></source>
<year>2021</year>
<volume>68</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>196-207</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fajardo-Montañana]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Villar]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez-Ansón]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Brea]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Mosqueira]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Molla]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Recomendaciones sobre el diagnóstico y seguimiento radiológico de los tumores neuroendocrinos hipofisarios.]]></article-title>
<source><![CDATA[Endocrinol, Diabetes Nutr]]></source>
<year>2022</year>
<volume>69</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>744-61</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barahona Ulloa]]></surname>
<given-names><![CDATA[WF]]></given-names>
</name>
<name>
<surname><![CDATA[García Iñigueza]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
<name>
<surname><![CDATA[Jiménez Encaladab]]></surname>
<given-names><![CDATA[MG]]></given-names>
</name>
<name>
<surname><![CDATA[Sacoto Molina]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adenomas hipofisarios: características sociodemográficas, clínicas y terapéuticas de 250 casos.]]></article-title>
<source><![CDATA[Neurología Argentina]]></source>
<year>2021</year>
<volume>13</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>205-11</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Garavaglia]]></surname>
<given-names><![CDATA[FI]]></given-names>
</name>
<name>
<surname><![CDATA[Paoletti]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Herrera]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Pueyrredon]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Montevideo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cabanillas]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Viano]]></surname>
<given-names><![CDATA[JC.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Resultados y complicaciones en resección de tumores de hipófisis por endoscopia via nasal transesfenoidal.]]></article-title>
<source><![CDATA[REV ARGENT NEUROC]]></source>
<year>2021</year>
<volume>35</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>277-86</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Garay]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Rojas]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Alaba]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Flores]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Salcedo]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tratamiento quirúrgico endoscópico transesfenoidal de tumores de hipófisis en el Hospital Nacional Cayetano Heredia en Lima Perú: Resultados de una serie de casos.]]></article-title>
<source><![CDATA[Peru J Neurosurg]]></source>
<year>2020</year>
<volume>2</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>109-116.</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Irigaray Echarri]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ollero García-Agulló]]></surname>
<given-names><![CDATA[MD]]></given-names>
</name>
<name>
<surname><![CDATA[Iriarte Beroiz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[García Mouriz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Zazpe Cenoz]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Laguna Muro]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluación de protocolo de manejo periquirúrgico con glucocorticoides tras cirugía hipofisaria]]></article-title>
<source><![CDATA[Endocrinol Diabetes Nutr]]></source>
<year>2022</year>
<volume>69</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>338-344.</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shlomo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Dan]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Longo]]></surname>
<given-names><![CDATA[MD.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pituitary -tumor endocrinopathies.]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2020</year>
<volume>382</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>937-50</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fuentes-Fayos]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[García-Martínez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Herrera-Martínez]]></surname>
<given-names><![CDATA[AD]]></given-names>
</name>
<name>
<surname><![CDATA[Jiménez-Vacas]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Vázquez-Borrego]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Castaño]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Molecular determinants of the response to medical treatment of growth hormone secreting pituitary neuroendocrine tumors]]></article-title>
<source><![CDATA[Minerva Endocrinol]]></source>
<year>2019</year>
<volume>44</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>109-28</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
